Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) Non-Current Deffered Revenue (2020 - 2022)

Historic Non-Current Deffered Revenue for ImageneBio (IMA) over the last 3 years, with Q3 2022 value amounting to $2.5 million.

  • ImageneBio's Non-Current Deffered Revenue fell 8884.08% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year decrease of 8884.08%. This contributed to the annual value of $7.7 million for FY2021, which is 7815.09% down from last year.
  • ImageneBio's Non-Current Deffered Revenue amounted to $2.5 million in Q3 2022, which was down 8884.08% from $3.8 million recorded in Q2 2022.
  • ImageneBio's Non-Current Deffered Revenue's 5-year high stood at $35.1 million during Q4 2020, with a 5-year trough of $2.5 million in Q3 2022.
  • Over the past 3 years, ImageneBio's median Non-Current Deffered Revenue value was $15.0 million (recorded in 2021), while the average stood at $16.6 million.
  • Per our database at Business Quant, ImageneBio's Non-Current Deffered Revenue tumbled by 7815.09% in 2021 and then crashed by 8884.08% in 2022.
  • Over the past 3 years, ImageneBio's Non-Current Deffered Revenue (Quarter) stood at $35.1 million in 2020, then plummeted by 78.15% to $7.7 million in 2021, then crashed by 67.41% to $2.5 million in 2022.
  • Its Non-Current Deffered Revenue was $2.5 million in Q3 2022, compared to $3.8 million in Q2 2022 and $4.6 million in Q1 2022.